ThetaRho vs Zus Health
Two ways to buy the same underlying capability, assembled records that software can use. Zus assembles and maintains the longitudinal record across thousands of provider sites, prescription fills and admission alerts, with the most detailed consent architecture in this index and a published match rate that admits identity resolution is imperfect. ThetaRho sells the same job in three separable layers, so an organisation with clean data can buy only the intelligence and one drowning in raw feeds can buy only the normalisation. The architectural difference decides it: Zus is multi tenant by design and cross tenant sharing is the property that makes it work, so there is no single tenant version, and for some organisations that is the end of the conversation.
- It sells the stack in three separable layers, normalisation, intelligence and applications, so a buyer takes only the part they lack.
- Four record systems are named explicitly alongside the national exchange networks, wearables and monitoring feeds.
- It names the models it runs on, which is a governance disclosure in itself and lets a buyer reason about the supply chain.
- It assembles and maintains the longitudinal record itself across thousands of provider sites, prescription fills and admission alerts, deduplicated and normalised.
- It publishes a match rate of roughly ninety percent, an explicit admission that identity resolution is imperfect.
- The consent architecture is described in more detail than almost anything in this index.
Side by Side
| Axis | T ThetaRho |
Z Zus Health |
|---|---|---|
| AI Centrality | ||
| Autonomy and Oversight Model | ||
| Model and Technology Transparency | ||
| Clinical and Operational Evidence | ||
| AI Safety and PHI Stewardship | ||
| HIPAA and BAA Posture | ||
| Security Certifications and Trust Center | ||
| FDA and Regulatory Status | ||
| AI Governance and Bias Disclosure | ||
| EHR and Interoperability Depth | ||
| Deployment Model and Data Residency | ||
| Commercial Transparency | ||
| Setting and Specialty Coverage |
Related comparisons
Other published head to head assessments involving these vendors or their closest peers. The full set for this category is on the Clinical Summarization & Chart Review page.
Both aggregate records from many organisations and neither publishes a security attestation or trust centre, which is consequential at this scale. Zus is multi tenant by design with cross tenant sharing as a central property, so no single tenant deployment exists, while ThetaRho's layered model lets a buyer take normalisation without the applications. Neither publishes pricing. Ask both what happens to a record that cannot be confidently resolved to a patient, because that is where aggregation errors become clinical ones.